Articles
Advancements in drug delivery
Advancements in drug delivery for women’s health and beyond
For over two decades, Lubrizol Life Science Health (LLS Health) has been a leader in the...
Clinical Trials
CyanVac Selects Exothera for the Development and GMP Mfg anufacturing of its COVID-19 Intranasal Vaccine Candidate for Phase III Clinical Trial is Europe and...
CyanVac LLC, a vaccine company, announced that they have selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), for the development and...
Press Releases
International Trade Body Warns Over Africa’s Fake Covid Vaccines
Africa’s law enforcement agencies are urged to step up their investment in anti-counterfeiting measures before the trade in fake Covid 19 vaccines spirals out...
Packaging & Labelling
Syntegon expands portfolio for the production of parenteral pharmaceuticals
Syntegon Technology has launched the new SVP Essential, a cost-efficient version of its proven Pharmatec SVP process systems for the production of small-volume liquid...
News
Stelis concludes US$ 195m Series B and Series C fund raise
Stelis Biopharma (Stelis) announced that it has successfully concluded its Series B and Series C fund raise for a cumulative amount of US$ 195m....
News
Peli BioThermal Broadens Portfolio of Dry Ice Shippers
Peli BioThermal, the global name in temperature controlled packaging, announces expanded dry ice shipper options to support exponential growth in cell and gene therapy...
Drug Research
Moderna Announces New Supply Agreement with the Philippines for 7 Million Additional Doses of COVID-19 Vaccine Moderna
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Philippines has secured 7 million additional doses of COVID-19...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read